arrow
R

Renate B. Schnabel

University of Birmingham
H指数:94
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early rhythm control in patients with atrial fibrillation and cancer: A subgroup analysis of the EAST-AFNET 4 trial

房颤合并癌症患者早期节律控制:EAST-AFNET 4试验的亚组分析

2026-09-180
OAAI
Environmental risk factors and cardiovascular health: A clinical consensus statement of the European Society of Cardiology

环境风险因素与心血管健康:欧洲心脏病学会临床共识声明

2026-05-070
PRE
Comprehensive assessment of novel cardiovascular biomarkers in AF

新型心血管生物标志物在房颤中的综合评估

2026-05-010
PRE
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference

通过针对合并症并减少心房颤动负荷来改变心房颤动管理:第10届AFNET/EHRA共识会议

2025-12-010
PRE
Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4

新近诊断房颤且伴有卒中风险因素患者中心房心肌病的患病率与严重程度及其与早期节律控制的关联:EAST-AFNET 4研究的二次分析

2025-10-010
OAAI
Outcomes and Management of Stressor-Associated Atrial Fibrillation

应力相关心房颤动的结局与管理

JACC
IF0
2025-09-150
PRE
Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trial

EAST-AFNET 4试验中早期节律控制对估计心房颤动负荷及心血管事件的影响

2025-09-010
OAAI
Occurrence of Coronary Events in the Absence of Traditional Risk Factors: Understanding Residual Risk (Arnold et al. Biomarker-related coronary risk in the community)

在缺乏传统风险因素的情况下冠状动脉事件的发生:理解残余风险(Arnold等.社区中生物标志物相关的冠状动脉风险)

2025-08-090
OAAI
Recent-onset atrial fibrillation: challenges and opportunities

新发心房颤动:挑战与机遇

2025-08-0112
PRE
Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial

心房颤动早期节律控制的短期获益:EAST-AFNET 4试验

2025-07-013
OAAI
Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

脂蛋白(a)与社区中冠心病的发生:传统心血管危险因素的影响

2025-07-013
OAAI